C. difficile

Showing 2 posts of 2 posts found.

Acurx Pharmaceuticals announces positive data from phase 2b trial for C. difficile infection treatment

October 3, 2023
Research and Development Acurx Pharmaceuticals, C. difficile, Infections and infestations, clinical trial, infection

Acurx Pharmaceuticals has announced that it has discontinued its phase 2b clinical trial of its lead antibiotic candidate, ibezapolstat, for …


Drop in prescriptions for antibiotic leads to fewer cases of superbug in Wales

August 20, 2019
Manufacturing and Production AMR, Antibiotics, C difficile, C. difficile, pharma, superbug

Cuts to the number of prescriptions for antibiotics have led to a drop in the number of cases of the …

Latest content